Galectin Therapeutics Reports Third Quarter and Nine Months 2011 Financial Results EON: Enhanced Online News (press release) There are currently no treatment options for liver fibrosis except liver transplantation.” “In the third quarter, Galectin Therapeutics continued to build the foundation for the development of our carbohydrate-based therapies for fibrotic liver disease ... Galectin Therapeutics Reports Third Quarter and Nine Months 2011 Financial Results |
